+91-9660032889
support@mysiponline.com
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Portfolio Analysis
- Others
- Index Fund
- Very High
-
₹19.47
(0.06%)
Current NAV 24-12-2024
-
29.37%
Returns
-
Min. SIP ₹100
Min. Investment ₹100
Fund Suitability Test
Asset Allocation (As on 31-May-2024)
Allocation of Equity and Debt Asset Classes.
- Equity 199.86%
- Debt 0.06%
- Others 0.08%
Market Cap Allocation Of Equity
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Large Cap | 80.2 |
| Others | 59.94 |
| Mid Cap | 47 |
| Small Cap | 12.72 |
Sector Allocation of Equity
Weightage of Portfolio Among Different Sectors.
Healthcare
Current Stocks Holdings of Equity
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 26-Dec-2024 |
Holdings | PE Ratio 26-Dec-2024 |
1Y Return |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Large Cap | Healthcare (48.89) | 13.29% | 39.97 | 47.75% |
| Sun Pharmaceutical Industries Ltd. | Large Cap | Healthcare (48.89) | 13.29% | 39.97 | 47.75% |
| Cipla Ltd. | Large Cap | Healthcare (48.89) | 7.24% | 26.89 | 19.64% |
| Cipla Ltd. | Large Cap | Healthcare (48.89) | 7.24% | 26.89 | 19.64% |
| Dr. Reddy's Laboratories Ltd. | Large Cap | Healthcare (48.49) | 6.48% | 19.53 | 18.18% |
| Dr. Reddy's Laboratories Ltd. | Large Cap | Healthcare (48.49) | 6.48% | 19.53 | 18.18% |
| Apollo Hospitals Enterprise Ltd. | Large Cap | Healthcare (97.63) | 5.66% | 87.81 | 28.28% |
| Apollo Hospitals Enterprise Ltd. | Large Cap | Healthcare (97.63) | 5.66% | 87.81 | 28.28% |
| Max Healthcare Institute Ltd. | Mid Cap | Healthcare (97.63) | 5.6% | 106.03 | 71.21% |
| Max Healthcare Institute Ltd. | Mid Cap | Healthcare (97.63) | 5.6% | 106.03 | 71.21% |
| Eli Lilly And Co | Healthcare | 5.26% | - | 0% | |
| Eli Lilly And Co | Healthcare | 5.26% | - | 0% | |
| Divi's Laboratories Ltd. | Large Cap | Healthcare (48.89) | 4.84% | 85.57 | 53.25% |
| Divi's Laboratories Ltd. | Large Cap | Healthcare (48.89) | 4.84% | 85.57 | 53.25% |
| Novo Nordisk A/S - ADR | Healthcare | 3.51% | - | 0% | |
| Novo Nordisk A/S - ADR | Healthcare | 3.51% | - | 0% | |
| Lupin Ltd. | Mid Cap | Healthcare (132.95) | 3.45% | 167.31 | 197.56% |
| Lupin Ltd. | Mid Cap | Healthcare (132.95) | 3.45% | 167.31 | 197.56% |
| Aurobindo Pharma Ltd. | Mid Cap | Healthcare (48.89) | 3% | 20.38 | 18.18% |
| Aurobindo Pharma Ltd. | Mid Cap | Healthcare (48.89) | 3% | 20.38 | 18.18% |
| Johnson & Johnson Ltd. | Healthcare | 2.81% | - | 0% | |
| Johnson & Johnson Ltd. | Healthcare | 2.81% | - | 0% | |
| Torrent Pharmaceuticals Ltd. | Large Cap | Healthcare (48.89) | 2.59% | 64.04 | 49.47% |
| Torrent Pharmaceuticals Ltd. | Large Cap | Healthcare (48.89) | 2.59% | 64.04 | 49.47% |
| Merck & Co Inc (US) | Healthcare | 2.53% | - | 0% | |
| Merck & Co Inc (US) | Healthcare | 2.53% | - | 0% | |
| AbbVie Inc | Healthcare | 2.26% | - | 0% | |
| AbbVie Inc | Healthcare | 2.26% | - | 0% | |
| Fortis Healthcare Ltd. | Mid Cap | Healthcare (97.63) | 2.16% | 77.91 | 70.89% |
| Fortis Healthcare Ltd. | Mid Cap | Healthcare (97.63) | 2.16% | 77.91 | 70.89% |
| Thermo Fisher Scientific Inc. | Healthcare | 1.75% | - | 0% | |
| Thermo Fisher Scientific Inc. | Healthcare | 1.75% | - | 0% | |
| Ipca Laboratories Ltd. | Mid Cap | Healthcare (48.89) | 1.58% | 61.12 | 50.43% |
| Ipca Laboratories Ltd. | Mid Cap | Healthcare (48.89) | 1.58% | 61.12 | 50.43% |
| Novartis AG | Healthcare | 1.57% | - | 0% | |
| Novartis AG | Healthcare | 1.57% | - | 0% | |
| Glenmark Pharmaceuticals Ltd. | Mid Cap | Healthcare (48.89) | 1.55% | -49.82 | 83.2% |
| Glenmark Pharmaceuticals Ltd. | Mid Cap | Healthcare (48.89) | 1.55% | -49.82 | 83.2% |
| Laurus Labs Ltd. | Small Cap | Healthcare (46.65) | 1.43% | 0 | 9.05% |
| Laurus Labs Ltd. | Small Cap | Healthcare (46.65) | 1.43% | 0 | 9.05% |
| Danaher Corporation | Healthcare | 1.43% | - | 0% | |
| Danaher Corporation | Healthcare | 1.43% | - | 0% | |
| Abbott Laboratories | Healthcare | 1.41% | - | 0% | |
| Abbott Laboratories | Healthcare | 1.41% | - | 0% | |
| Amgen Inc. (USA) | Healthcare | 1.3% | - | 0% | |
| Amgen Inc. (USA) | Healthcare | 1.3% | - | 0% | |
| Biocon Ltd. | Mid Cap | Healthcare (48.89) | 1.24% | 28.99 | 38.57% |
| Biocon Ltd. | Mid Cap | Healthcare (48.89) | 1.24% | 28.99 | 38.57% |
| JB Chemicals & Pharmaceuticals Ltd. | Small Cap | Healthcare (55.16) | 1.18% | 48.39 | 61.86% |
| JB Chemicals & Pharmaceuticals Ltd. | Small Cap | Healthcare (55.16) | 1.18% | 48.39 | 61.86% |
| Syngene International Ltd. | Mid Cap | Healthcare (71.84) | 1.16% | 70.18 | 20.01% |
| Syngene International Ltd. | Mid Cap | Healthcare (71.84) | 1.16% | 70.18 | 20.01% |
| Intuitive Surgical Inc. (USA) | Healthcare | 1.13% | - | 0% | |
| Intuitive Surgical Inc. (USA) | Healthcare | 1.13% | - | 0% | |
| Glaxosmithkline Pharmaceuticals Ltd. | Mid Cap | Healthcare (48.89) | 1% | 55.96 | 26.24% |
| Glaxosmithkline Pharmaceuticals Ltd. | Mid Cap | Healthcare (48.89) | 1% | 55.96 | 26.24% |
| Gland Pharma Ltd. | Mid Cap | Healthcare (48.89) | 0.98% | 43.36 | -3.72% |
| Gland Pharma Ltd. | Mid Cap | Healthcare (48.89) | 0.98% | 43.36 | -3.72% |
| Ajanta Pharma Ltd. | Mid Cap | Healthcare (48.89) | 0.97% | 39.97 | 41% |
| Ajanta Pharma Ltd. | Mid Cap | Healthcare (48.89) | 0.97% | 39.97 | 41% |
| Global Health Ltd. | Small Cap | Healthcare (97.63) | 0.94% | 60.81 | 14.64% |
| Global Health Ltd. | Small Cap | Healthcare (97.63) | 0.94% | 60.81 | 14.64% |
| Dr. Lal Pathlabs Ltd. | Small Cap | Healthcare (97.63) | 0.94% | 61.52 | 13.69% |
| Dr. Lal Pathlabs Ltd. | Small Cap | Healthcare (97.63) | 0.94% | 61.52 | 13.69% |
| Stryker Corp | Healthcare | 0.93% | - | 0% | |
| Stryker Corp | Healthcare | 0.93% | - | 0% | |
| Vertex Pharmaceuticals Inc. (USA) | Healthcare | 0.93% | - | 0% | |
| Vertex Pharmaceuticals Inc. (USA) | Healthcare | 0.93% | - | 0% | |
| Medtronic | Healthcare | 0.86% | - | 0% | |
| Medtronic | Healthcare | 0.86% | - | 0% | |
| Narayana Hrudayalaya Ltd. | Mid Cap | Healthcare (97.63) | 0.81% | 34.32 | 10.39% |
| Narayana Hrudayalaya Ltd. | Mid Cap | Healthcare (97.63) | 0.81% | 34.32 | 10.39% |
| Sanofi India Ltd. | Small Cap | Healthcare (24.65) | 0.67% | 8.73 | 145.06% |
| Sanofi India Ltd. | Small Cap | Healthcare (24.65) | 0.67% | 8.73 | 145.06% |
| Gilead Sciences Inc. (USA) | Healthcare | 0.64% | - | 0% | |
| Gilead Sciences Inc. (USA) | Healthcare | 0.64% | - | 0% | |
| Suven Pharmaceuticals Ltd. | Small Cap | Healthcare (48.89) | 0.6% | 120.18 | 61.76% |
| Suven Pharmaceuticals Ltd. | Small Cap | Healthcare (48.89) | 0.6% | 120.18 | 61.76% |
| Pfizer Ltd. | Small Cap | Healthcare (48.89) | 0.6% | 0 | 14.67% |
| Pfizer Ltd. | Small Cap | Healthcare (48.89) | 0.6% | 0 | 14.67% |
| Becton Dickinson And Co | Healthcare | 0.53% | - | 0% | |
| Becton Dickinson And Co | Healthcare | 0.53% | - | 0% | |
| Moderna Inc | Healthcare | 0.37% | - | 0% | |
| Moderna Inc | Healthcare | 0.37% | - | 0% | |
| Iqvia Holdings | Healthcare | 0.32% | - | 0% | |
| Iqvia Holdings | Healthcare | 0.32% | - | 0% | |
| Agilent Technologies Inc | Healthcare | 0.3% | - | 0% | |
| Agilent Technologies Inc | Healthcare | 0.3% | - | 0% | |
| Illumina Inc. (USA) | Healthcare | 0.13% | - | 0% | |
| Illumina Inc. (USA) | Healthcare | 0.13% | - | 0% |
Discover More with Premium Access
View Stock InformationMarket Cap Allocation Of Debt
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Others | 0.06 |
Sector Allocation of Debt
Weightage of Portfolio Among Different Sectors.
Others
Current Stocks Holdings of Debt
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 01-Jan-1970 |
Holdings | PE Ratio 01-Jan-1970 |
1Y Return |
|---|---|---|---|---|---|
| Others | Others | 0.03% | - | 0% | |
| Others | Others | 0.03% | - | 0% |
Discover More with Premium Access
View Stock InformationMarket Cap Allocation Of Others
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Others | 0.08 |
Sector Allocation of Others
Weightage of Portfolio Among Different Sectors.
Others
Current Stocks Holdings of Others
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 01-Jan-1970 |
Holdings | PE Ratio 01-Jan-1970 |
1Y Return |
|---|---|---|---|---|---|
| Others | Others | 0.04% | - | 0% | |
| Others | Others | 0.04% | - | 0% |
Discover More with Premium Access
View Stock Information
Take test again
Chat with usFrequently Asked Questions
What is Market cap allocation in the portfolio?
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.
Top 5 holdings for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund ?
The top holdings of this fund are
How do I create a good mutual fund portfolio?
Building a good portfolio requires proper research and knowing about goals that need to be achieved. Set a boundary for your risk capacity, study about different funds and look at its past performance. Balance portfolio according to set goals and stay informed.
How to maintain a good portfolio?
Timely monitoring of the portfolio keeps us aware of the changes in the ongoing market trends. It helps in making plans for any policy change.
What is sector allocation in the portfolio?
The distribution of assets among various economic sectors is referred to as sector allocation in a portfolio. These sectors include technology, healthcare, financial, energy, and many others.
Top 5 Sector for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund ?
The major sectors of this fund are .
What is the ideal number of funds to have in a portfolio?
There is no ideal number, but it is always advisable to keep 4-5 funds in the portfolio as it can be easy to manage them and correct decisions can be taken according to it. Diversification is the key to manage and balance your portfolio for smooth growth.
How does risk tolerance play a role in determining portfolio allocation?
Risk tolerance is an important factor in maintaining portfolio allocation. With the correct mix of assets, the value of investments can improve significantly.